Kumbh Mela 2021: Head of Maha Nirvani Akhara suffering from COVID-19 dies in Uttarakhand

The akhara's Mahamandaleshwar, who had come to attend the ongoing Kumbh Mela in Haridwar from Madhya Pradesh, was admitted to the Kailash Hospital in Dehradun after his RT-PCR test result, Haridwar's Chief Medical Officer S K Jha said.

PTI
April 15, 2021 / 06:56 PM IST

Image: AFP

The head of the Maha Nirvani Akhara from Madhya Pradesh Swami Kapil Dev who was under treatment for COVID-19 at a private hospital has died, an official said on Thursday.

The akhara's Mahamandaleshwar, who had come to attend the ongoing Kumbh Mela in Haridwar from Madhya Pradesh, was admitted to the Kailash Hospital in Dehradun after his RT-PCR test result, Haridwar's Chief Medical Officer S K Jha said.

Swami Kapil Dev passed away at the hospital on April 13, Superintendent of Police (City) Sarita Dobhal said.

Over 1,700 people have tested positive for COVID-19 in the Haridwar Kumbh Mela area from April 10 to 14 confirming fears that one of the world's largest religious gatherings may contribute further to the rapid rise in coronavirus cases.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Medical workers conducted 2,36,751 tests over the five-day period in the mela site. Out of these, 1,701 came out positive for coronavirus.

The numbers include both RT-PCR and Rapid Antigen Test reports of devotees and seers of different akharas (ascetic groups) over the five-day period in the entire mela site extending from Haridwar to Devprayag, Jha said.

More RT-PCR test reports are awaited and the trend shows that the number of infected persons in the Kumbh Mela site is likely to climb to 2,000, he said.

The Kumbh Mela area is spread over 670 hectares covering parts of Haridwar, Tehri and Dehradun districts, including Rishikesh.

A majority of the 48.51 lakh people who took part in the last two 'royal baths' (shahi snan) held on the occasion of Somwati Amavasya on April 12 and Mesh Sankranti on April 14 were seen openly violating COVID norms like wearing face masks and maintaining social distancing.

Despite their best efforts, the police could not impose the standard operating procedures (SOPs) on the seers of akharas and the ash-smeared ascetics thronging Har Ki Pairi ghat on the two major bathing days due to severe time constraints.
PTI
TAGS: #coronavirus #Current Affairs #India #Kumbh Mela 2021 #Uttarakhand
first published: Apr 15, 2021 06:55 pm